Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib in USP8-mutated Cushing's Disease
NCT02484755Phase 2Unknown
- Sponsor
- Huashan Hospital
- Start
- Jun 2015
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in Cushing's disease (CD), sponsored by Huashan Hospital. Status: unknown.
02
Drugs
03
Conditions
Cushing's disease (CD)
Beyond the preview
Go deeper on NCT02484755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02484755.